Filing Details
- Accession Number:
- 0001219036-18-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-13 16:25:22
- Reporting Period:
- 2018-07-11
- Accepted Time:
- 2018-07-13 16:25:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899923 | Myriad Genetics Inc | MYGN | In Vitro & In Vivo Diagnostic Substances (2835) | 870494517 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219036 | S Jerry Lanchbury | 320 Wakara Way Salt Lake City UT 84108 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-07-11 | 46,139 | $30.34 | 184,948 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-07-11 | 46,139 | $43.34 | 138,809 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-07-11 | 3,861 | $30.34 | 142,670 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-07-11 | 3,861 | $43.34 | 138,809 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2018-07-11 | 3,861 | $0.00 | 3,861 | $30.34 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-07-11 | 46,139 | $0.00 | 46,139 | $30.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-09-15 | 2019-09-15 | No | 4 | M | Direct |
0 | 2013-09-15 | 2019-09-15 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.